Loading
Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.
Previous close
$4.97
−$0.30 · -5.69%
After-hours
$4.99
+$0.02 · +0.40%
Sep 4, 7:30 PM ET
Regular session · ET · Market data may be delayed.
Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.
Day range
Current $4.97
52-week range
Current $4.97
Regular session · ET · Market data may be delayed.
Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.
Day range
Current $4.97
52-week range
Current $4.97
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$20.00
302.41% upsideAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
